Paul P et al. |
Capillary electrophoresis with capacitively coupled contactless conductivity detection method development and validation for the determination of azithromycin, clarithromycin, and clindamycin. |
2017 |
J Sep Sci |
pmid:28683179
|
Katayama Y et al. |
Neuroprotective effects of clarithromycin against neuronal damage in cerebral ischemia and in cultured neuronal cells after oxygen-glucose deprivation. |
2017 |
Life Sci. |
pmid:27825902
|
Moj D et al. |
Clarithromycin, Midazolam, and Digoxin: Application of PBPK Modeling to Gain New Insights into Drug-Drug Interactions and Co-medication Regimens. |
2017 |
AAPS J |
pmid:27822600
|
Akpinar Z et al. |
Improving the standard sequential treatment of Helicobacter pylori with either extended treatment or by adding bismuth. |
2017 |
Arab J Gastroenterol |
pmid:28532623
|
Beckman E et al. |
A Novel Stool PCR Test for Helicobacter pylori May Predict Clarithromycin Resistance and Eradication of Infection at a High Rate. |
2017 |
J. Clin. Microbiol. |
pmid:28515219
|
Kajihara Y et al. |
Analysis of the cost-effectiveness of using vonoprazan-amoxicillin-clarithromycin triple therapy for first-line Helicobacter pylori eradication. |
2017 |
Scand. J. Gastroenterol. |
pmid:27806639
|
Yan J et al. |
Survey about the use of clarithromycin in an ENT outpatient department of a tertiary hospital. |
2017 |
Eur Arch Otorhinolaryngol |
pmid:28508178
|
Shaulov A et al. |
Progressive refractory light chain amyloidosis and multiple myeloma patients are responsive to the addition of clarithromycin to IMiD based therapy. |
2017 |
Am. J. Hematol. |
pmid:27804150
|
DaCosta A et al. |
Outcomes associated with antibiotic regimens for treatment of Mycobacterium abscessus in cystic fibrosis patients. |
2017 |
J. Cyst. Fibros. |
pmid:28495380
|
Malfertheiner P et al. |
Management of Helicobacter pylori infection-the Maastricht V/Florence Consensus Report. |
2017 |
Gut |
pmid:27707777
|
Sharifi R et al. |
Dietary PUFA Increase Apoptosis in Stomach of Patients with Dyspeptic Symptoms and Infected with H. pylori. |
2017 |
Lipids |
pmid:28493185
|
Morimoto K et al. |
A Laboratory-based Analysis of Nontuberculous Mycobacterial Lung Disease in Japan from 2012 to 2013. |
2017 |
Ann Am Thorac Soc |
pmid:27788025
|
Reddy AB and Reddy ND |
Development of Multiple-Unit Floating Drug Delivery System of Clarithromycin: Formulation, in vitro Dissolution by Modified Dissolution Apparatus, in vivo Radiographic Studies in Human Volunteers. |
2017 |
Drug Res (Stuttg) |
pmid:28449156
|
Aktas AH and Saridag AM |
Liquid Chromatographic-Chemometric Techniques for the Simultaneous HPLC Determination of Lansoprazole, Amoxicillin and Clarithromycin in Commercial Preparation. |
2017 |
J Chromatogr Sci |
pmid:28449104
|
Itskoviz D et al. |
Smoking increases the likelihood of Helicobacter pylori treatment failure. |
2017 |
Dig Liver Dis |
pmid:28427781
|
Koštrun S et al. |
Around the macrolide - Impact of 3D structure of macrocycles on lipophilicity and cellular accumulation. |
2017 |
Eur J Med Chem |
pmid:28410508
|
Wong AYS et al. |
Managing Cardiovascular Risk of Macrolides: Systematic Review and Meta-Analysis. |
2017 |
Drug Saf |
pmid:28397186
|
Baluch A et al. |
Successful management of Mycobacterium haemophilum lower extremity cutaneous infection in a matched-unrelated donor stem cell transplant recipient. |
2017 |
Transpl Infect Dis |
pmid:27775824
|
Aziz DB et al. |
Rifabutin Is Active against Mycobacterium abscessus Complex. |
2017 |
Antimicrob. Agents Chemother. |
pmid:28396540
|
Maruyama M et al. |
Vonoprazan-Based Regimen Is More Useful than PPI-Based One as a First-Line Eradication: A Randomized Controlled Trial. |
2017 |
Can J Gastroenterol Hepatol |
pmid:28349044
|
Brouqui P et al. |
Old antibiotics for emerging multidrug-resistant/extensively drug-resistant tuberculosis (MDR/XDR-TB). |
2017 |
Int. J. Antimicrob. Agents |
pmid:28336312
|
Xu YF et al. |
and Antibacterial Activities of Patchouli Alcohol, a Naturally Occurring Tricyclic Sesquiterpene, against Helicobacter pylori Infection. |
2017 |
Antimicrob. Agents Chemother. |
pmid:28320722
|
Yang YJ et al. |
Ten days of levofloxacin-containing concomitant therapy can achieve effective Helicobacter pylori eradication in patients with type 2 diabetes. |
2017 |
Ann. Med. |
pmid:28266875
|
Giguère S et al. |
Antimicrobial Resistance in . |
2017 |
Microbiol Spectr |
pmid:29052538
|
Yoon HY et al. |
Clinical significance of QT-prolonging drug use in patients with MDR-TB or NTM disease. |
2017 |
Int. J. Tuberc. Lung Dis. |
pmid:28826448
|
Giguère S |
Treatment of Infections Caused by Rhodococcus equi. |
2017 |
Vet. Clin. North Am. Equine Pract. |
pmid:28161038
|
Berni E et al. |
Risk of cardiovascular events, arrhythmia and all-cause mortality associated with clarithromycin versus alternative antibiotics prescribed for respiratory tract infections: a retrospective cohort study. |
2017 |
BMJ Open |
pmid:28115334
|
Yoon H et al. |
Eradication Downregulates Cellular Inhibitor of Apoptosis Protein 2 in Gastric Carcinogenesis. |
2017 |
Gut Liver |
pmid:27282269
|
Yatera K et al. |
The additive effect of clarithromycin on influenza A infection in the elderly patients and patients with comorbid diseases. |
2017 |
Respir Investig |
pmid:29153420
|
Lee MC et al. |
Antimicrobial resistance in Mycobacterium abscessus complex isolated from patients with skin and soft tissue infections at a tertiary teaching hospital in Taiwan. |
2017 |
J. Antimicrob. Chemother. |
pmid:29091186
|
Costa S et al. |
Efficacy and tolerability of culture-guided treatment for Helicobacter pylori infection. |
2017 |
Eur J Gastroenterol Hepatol |
pmid:28877088
|
Pryjma M et al. |
Antagonism between Front-Line Antibiotics Clarithromycin and Amikacin in the Treatment of Mycobacterium abscessus Infections Is Mediated by the Gene. |
2017 |
Antimicrob. Agents Chemother. |
pmid:28874379
|
Santos RP et al. |
induced rash and mucositis: a recently described entity. |
2017 |
BMJ Case Rep |
pmid:28830900
|
Takahashi C et al. |
Morphological study of efficacy of clarithromycin-loaded nanocarriers for treatment of biofilm infection disease. |
2017 |
Med Mol Morphol |
pmid:27119723
|
Kwon S et al. |
[The Efficacy of Moxifloxacin-containing Triple Therapy after Hybrid Therapy Failure in Eradication]. |
2017 |
Korean J Gastroenterol |
pmid:28830132
|
Nanishi E et al. |
Clarithromycin Plus Intravenous Immunoglobulin Therapy Can Reduce the Relapse Rate of Kawasaki Disease: A Phase 2, Open-Label, Randomized Control Study. |
2017 |
J Am Heart Assoc |
pmid:28684643
|
Boal Carvalho P et al. |
Randomized Controlled Trial for Helicobacter pylori Eradication in a Naive Portuguese Population: Is Sequential Treatment Superior to Triple Therapy in Real World Clinical Setting? |
2017 |
Acta Med Port |
pmid:28550827
|
Shah SA et al. |
Clarithromycin inhibits TNF-α-induced MUC5AC mucin gene expression via the MKP-1-p38MAPK-dependent pathway. |
2017 |
Int. Immunopharmacol. |
pmid:28550735
|
Jakubů V et al. |
Trends in the Minimum Inhibitory Concentrations of Erythromycin, Clarithromycin, Azithromycin, Ciprofloxacin, and Trimethoprim/Sulfamethoxazole for Strains of Bordetella pertussis isolated in the Czech Republic in 1967-2015. |
2017 |
Cent. Eur. J. Public Health |
pmid:29346850
|
Laidler N |
Cutaneous infection with paucibacillary treated successfully with a modified antituberculous drug regimen. |
2017 |
BMJ Case Rep |
pmid:29275384
|
Lee JS et al. |
Implication of species change of Nontuberculous Mycobacteria during or after treatment. |
2017 |
BMC Pulm Med |
pmid:29262802
|
Ruiter R et al. |
Helicobacter pylori resistance in the Netherlands: a growing problem? |
2017 |
Neth J Med |
pmid:29219812
|
Vaz AM et al. |
Capsule endoscopy in the diagnosis of disseminated complex infection. |
2017 |
BMJ Case Rep |
pmid:29167222
|
Lee H et al. |
Concomitant, sequential, and 7-day triple therapy in first-line treatment of Helicobacter pylori infection in Korea: study protocol for a randomized controlled trial. |
2017 |
Trials |
pmid:29149904
|
Tsay FW et al. |
A Randomized Controlled Trial Shows that both 14-Day Hybrid and Bismuth Quadruple Therapies Cure Most Patients with Helicobacter pylori Infection in Populations with Moderate Antibiotic Resistance. |
2017 |
Antimicrob. Agents Chemother. |
pmid:28807915
|
Oh ES et al. |
Effects of clarithromycin on the pharmacokinetics of evogliptin in healthy volunteers. |
2017 |
J Clin Pharm Ther |
pmid:28806472
|
Kuo YT et al. |
Primary antibiotic resistance in Helicobacter pylori in the Asia-Pacific region: a systematic review and meta-analysis. |
2017 |
Lancet Gastroenterol Hepatol |
pmid:28781119
|
Ramas M et al. |
Efficacy and safety of rifaximin associated with standard triple therapy (omeprazole, clarithromycin and amoxicillin) for H. pylori eradication: A phase IV pilot clinical trial. |
2017 |
Gastroenterol Hepatol |
pmid:28780968
|
Painsi C and Lange-Asschenfeldt B |
Image Gallery: Pink papules within a tattoo linked to Mycobacterium chelonae infection. |
2017 |
Br. J. Dermatol. |
pmid:28731256
|
Fremlin GA et al. |
Clarithromycin, rifampicin and fusidic acid triple combination therapy for chronic folliculocentric pustulosis of the scalp. |
2017 |
Clin. Exp. Dermatol. |
pmid:28691163
|
Andere NMRB et al. |
Clarithromycin as an Adjunct to One-Stage Full-Mouth Ultrasonic Periodontal Debridement in Generalized Aggressive Periodontitis: A Randomized Controlled Clinical Trial. |
2017 |
J. Periodontol. |
pmid:28671507
|
Adachi T et al. |
Comparative Study of Clarithromycin- versus Metronidazole-Based Triple Therapy as First-Line Eradication for Helicobacter pylori. |
2017 |
Oncology |
pmid:29258111
|
Moon SH et al. |
Novel Linear Lipopeptide Paenipeptins with Potential for Eradicating Biofilms and Sensitizing Gram-Negative Bacteria to Rifampicin and Clarithromycin. |
2017 |
J. Med. Chem. |
pmid:29136469
|
Feng L et al. |
Removal of antibiotics during the anaerobic digestion of pig manure. |
2017 |
Sci. Total Environ. |
pmid:28628813
|
Mougari F et al. |
Selection of Resistance to Clarithromycin in Mycobacterium abscessus Subspecies. |
2017 |
Antimicrob. Agents Chemother. |
pmid:27799212
|
Hu Y et al. |
Novel and Effective Therapeutic Regimens for in an Era of Increasing Antibiotic Resistance. |
2017 |
Front Cell Infect Microbiol |
pmid:28529929
|
Jeong SH et al. |
Mycobacteriological characteristics and treatment outcomes in extrapulmonary Mycobacterium abscessus complex infections. |
2017 |
Int. J. Infect. Dis. |
pmid:28522316
|
Kishida D et al. |
Intractable Cutaneous Nontuberculous Mycobacteriosis (Mycobacterium abscessus) during Treatment for Systemic Lupus Erythematosus. |
2017 |
Intern. Med. |
pmid:28502947
|
Jung YS et al. |
Systematic review with meta-analysis: the efficacy of vonoprazan-based triple therapy on Helicobacter pylori eradication. |
2017 |
Aliment. Pharmacol. Ther. |
pmid:28497487
|
Sharman MJ et al. |
Gastrokine mRNA expression in gastric tissue from dogs with helicobacter colonisation but without inflammatory change during treatment. |
2017 |
Vet. Immunol. Immunopathol. |
pmid:28494926
|
O'Brien CR et al. |
Feline leprosy due to Candidatus 'Mycobacterium tarwinense':Further clinical and molecular characterisation of 15 previously reported cases and an additional 27 cases |
2017 |
J. Feline Med. Surg. |
pmid:28438086
|
Tan B et al. |
Polaprezinc combined with clarithromycin-based triple therapy for Helicobacter pylori-associated gastritis: A prospective, multicenter, randomized clinical trial. |
2017 |
PLoS ONE |
pmid:28407007
|
Freyne B and Curtis N |
Mycobacterium gordonae Skin Infection in an Immunocompetent Child. |
2017 |
Pediatr. Infect. Dis. J. |
pmid:28403059
|
Bustamante-Rengifo JA et al. |
Effect of treatment failure on the CagA EPIYA motif in strains from Colombian subjects. |
2017 |
World J. Gastroenterol. |
pmid:28373764
|
Marin AC et al. |
Efficacy and Safety of Quinolone-Containing Rescue Therapies After the Failure of Non-Bismuth Quadruple Treatments for Helicobacter pylori Eradication: Systematic Review and Meta-Analysis. |
2017 |
Drugs |
pmid:28361211
|
Holmberg LA et al. |
Results from Two Consecutive Studies of Consolidation Therapy after Autologous Transplant for Multiple Myeloma: Thalidomide, Dexamethasone, and Clarithromycin or Lenalidomide, Dexamethasone, and Clarithromycin. |
2017 |
Acta Haematol. |
pmid:28355602
|
Smith S et al. |
The Irish Helicobacter pylori Working Group consensus for the diagnosis and treatment of H. pylori infection in adult patients in Ireland. |
2017 |
Eur J Gastroenterol Hepatol |
pmid:28350745
|
Mougari F et al. |
Evaluation of the new GenoType NTM-DR kit for the molecular detection of antimicrobial resistance in non-tuberculous mycobacteria. |
2017 |
J. Antimicrob. Chemother. |
pmid:28333340
|
Kristin F et al. |
Dissolution and dissolution/permeation experiments for predicting systemic exposure following oral administration of the BCS class II drug clarithromycin. |
2017 |
Eur J Pharm Sci |
pmid:28179133
|
Chen D et al. |
Phenotypic and Molecular Antimicrobial Susceptibility of Helicobacter pylori. |
2017 |
Antimicrob. Agents Chemother. |
pmid:28167563
|
Olesen JS et al. |
Mycobacterium chelonae hand infection after steroid injection in a patient with rheumatoid arthritis receiving long-term linezolid therapy. |
2017 |
BMJ Case Rep |
pmid:28137898
|
Chang JY et al. |
Triple therapy versus sequential therapy for the first-line Helicobacter pylori eradication. |
2017 |
BMC Gastroenterol |
pmid:28109257
|
Sasaoka Y et al. |
Neonatal apnea with Chlamydia pneumoniae infection. |
2017 |
Pediatr Int |
pmid:28102626
|
Lapa GB et al. |
Two approaches to the use of benzo[c][1,2]oxaboroles as active fragments for synthetic transformation of clarithromycin. |
2017 |
J Enzyme Inhib Med Chem |
pmid:28097898
|
Chen PY et al. |
Letter: levofloxacin resistance - a challenge for treatment of Helicobacter pylori infection. Authors' reply. |
2017 |
Aliment. Pharmacol. Ther. |
pmid:28074519
|
Zamani M et al. |
Letter: levofloxacin resistance - a challenge for the treatment of Helicobacter pylori infection. |
2017 |
Aliment. Pharmacol. Ther. |
pmid:28074507
|
Chey WD et al. |
ACG Clinical Guideline: Treatment of Helicobacter pylori Infection. |
2017 |
Am. J. Gastroenterol. |
pmid:28071659
|
Fernández Martos R et al. |
Acute psychotic episode secondary to Helicobacter pylori eradication treatment. |
2017 |
Rev Esp Enferm Dig |
pmid:28071063
|
Ko J et al. |
Delayed onset Mycobacterium intracellulare keratitis after laser in situ keratomileusis: A case report and literature review. |
2017 |
Medicine (Baltimore) |
pmid:29390522
|
Takeuchi S et al. |
Hypotension induced by the concomitant use of a calcium-channel blocker and clarithromycin. |
2017 |
BMJ Case Rep |
pmid:28069789
|
Stjepanovic MI et al. |
Pulmonary and Vertebral Mycobacterium avium Disease in a HIV-negative 71-year-old Man - A Case Report. |
2016 |
Infez Med |
pmid:28011973
|
Muñoz-Egea MC et al. |
Effect of Antibiotics and Antibiofilm Agents in the Ultrastructure and Development of Biofilms Developed by Nonpigmented Rapidly Growing Mycobacteria. |
2016 |
Microb. Drug Resist. |
pmid:26208145
|
Salimi A et al. |
Toxicity of macrolide antibiotics on isolated heart mitochondria: a justification for their cardiotoxic adverse effect. |
2016 |
Xenobiotica |
pmid:26068526
|
Campillo A et al. |
[10-day triple therapy with esomeprazole 40 mg/12 h vs. quadruple concomitant non-bismuth therapy as first line treatment for Helicobacter pylori infection]. |
2016 |
Gastroenterol Hepatol |
pmid:27084668
|
Chauffour A et al. |
Sterilizing Activity of Fully Oral Intermittent Regimens against Mycobacterium Ulcerans Infection in Mice. |
2016 |
PLoS Negl Trop Dis |
pmid:27755552
|
Abuhammour A et al. |
Standard triple therapy versus sequential therapy for eradication of Helicobacter pylori in treatment naïve and retreat patients. |
2016 |
Arab J Gastroenterol |
pmid:27665525
|
Christianson S et al. |
Time-to-Detection of Inducible Macrolide Resistance in Mycobacterium abscessus Subspecies and Its Association with the Erm(41) Sequevar. |
2016 |
PLoS ONE |
pmid:27490181
|
Steurer J |
[Months of antibiotic therapy in persistent symptoms of Lyme disease without effect]. |
2016 |
Praxis (Bern 1994) |
pmid:27269781
|
Chung JW et al. |
Ten-day empirical sequential or concomitant therapy is more effective than triple therapy for Helicobacter pylori eradication: A multicenter, prospective study. |
2016 |
Dig Liver Dis |
pmid:27257049
|
Mitchell H and Katelaris P |
Epidemiology, clinical impacts and current clinical management of Helicobacter pylori infection. |
2016 |
Med. J. Aust. |
pmid:27256648
|
Parize P et al. |
Induction therapy with linezolid/clarithromycin combination for Mycobacterium chelonae skin infections in immunocompromised hosts. |
2016 |
J Eur Acad Dermatol Venereol |
pmid:25677464
|
Graham DY and Dore MP |
Helicobacter pylori therapy: a paradigm shift. |
2016 |
Expert Rev Anti Infect Ther |
pmid:27077447
|
Song ZQ et al. |
Hybrid Therapy Regimen for Helicobacter Pylori Eradication. |
2016 |
Chin. Med. J. |
pmid:27064046
|
Matsumoto H et al. |
Molecular Detection of H. pylori Using Adherent Gastric Mucous to Biopsy Forceps. |
2016 |
Helicobacter |
pmid:27061611
|
Bakshi SS |
Outcome evaluation of clarithromycin, metronidazole and lansoprazole regimens in Helicobacter pylori positive or negative children with resistant otitis media with effusion. |
2016 |
J Laryngol Otol |
pmid:26878377
|
Franceschi F et al. |
High dose amoxicillin-based first line regimen is equivalent to sequential therapy in the eradication of H. pylori infection. |
2016 |
Eur Rev Med Pharmacol Sci |
pmid:26875899
|
Vermeer LM et al. |
Evaluation of Ketoconazole and Its Alternative Clinical CYP3A4/5 Inhibitors as Inhibitors of Drug Transporters: The In Vitro Effects of Ketoconazole, Ritonavir, Clarithromycin, and Itraconazole on 13 Clinically-Relevant Drug Transporters. |
2016 |
Drug Metab. Dispos. |
pmid:26668209
|
Meng Y et al. |
Multi-functional Liposomes Enhancing Target and Antibacterial Immunity for Antimicrobial and Anti-Biofilm Against Methicillin-Resistant Staphylococcus aureus. |
2016 |
Pharm. Res. |
pmid:26666773
|
Kamiya K et al. |
Erythema multiforme caused by triple therapy with amoxicillin, clarithromycin and vonoprazan for Helicobacter pylori. |
2016 |
J. Dermatol. |
pmid:26508502
|
Mark TM and Coleman M |
It's Time to Take Clarithromycin Seriously in Multiple Myeloma. |
2016 |
Acta Haematol. |
pmid:26505907
|